Skip to main content
Log in

Clinical Experience in Invasive Fungal Infections

  • Case Report
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

Lung infections caused by invasive filamentous fungi are very rare conditions in AIDS, but must be considered in patients with profound immune suppression especially in the presence of additional risk factors, such as hematologic malignancies, corticosteroid therapy, neutropenia, and chemotherapy. The authors report a case of dual lung infection caused by Aspergillus and Mucor, which occurred in a 34-year-old AIDS patient who was treated with chemotherapy for oral plasmablastic lymphoma. The case presented clinically with low grade fever and pulmonary cavitation, which suggested tuberculosis. After extensive investigation the diagnosis of mucormycosis was established and the patient was treated sequentially with liposomal amphotericin B and posaconazole. Despite a reduction in the size of the pulmonary cavitation, improvement of the lung interstitial infiltrates and clinical recovery, the patient was submitted to cardiothoracic surgery given the aggressive behavior of this invasive fungus. Histology of the surgical specimen showed numerous hyphae with a morphologic pattern compatible with Aspergillus as well as hyphae that were suggestive of Mucor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin N Am. 2002;16:895–914.

    Article  Google Scholar 

  2. Rinaldi MG. Zygomycosis. Infect Dis Clin N Am. 1989;3:19–41.

    CAS  Google Scholar 

  3. Donohue JF. Endobronchialmucormycosis. Chest. 1983;83:585.

    Article  PubMed  CAS  Google Scholar 

  4. Lass-Florl C. Zygomycosis: conventional laboratory diagnosis. Clin Microbiol Infect. 2009;15(Suppl 5):60–5.

    Article  PubMed  Google Scholar 

  5. Alvarez E, Sutton DA, Cano J, et al. Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol. 2009;47:1650–6.

    Article  PubMed  CAS  Google Scholar 

  6. Dannaoui E. Molecular tools for identification of Zygomycetes and the diagnosis of zygomycosis. Clin Microbiol Infect. 2009;15(Suppl 5):66–70.

    Article  PubMed  CAS  Google Scholar 

  7. Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57:1044–50.

    Article  PubMed  CAS  Google Scholar 

  8. Alastruey-Izquierdo A, Castelli MV, Cuesta I, et al. In vitro activity of antifungals against Zygomycetes. Clin Microbiol Infect. 2009;15(Suppl 5):71–6.

    Article  PubMed  CAS  Google Scholar 

  9. Cornely OA, Vehreschild JJ, Rüping MJ. Current experience in treating invasive zygomycosis with posaconazole. Clin Microbiol Infect. 2009;15(Suppl 5):77–81.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

This manuscript has been published in a journal supplement that was created with an unrestricted educational grant from Gilead Portugal. Patricia Pachego has received fees for consultancy from Gilead Sciences and Merck. The other authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrícia Pacheco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pacheco, P., Ventura, A.S., Branco, T. et al. Clinical Experience in Invasive Fungal Infections. Clin Drug Investig 33 (Suppl 1), 23–26 (2013). https://doi.org/10.1007/s40261-012-0017-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40261-012-0017-1

Keywords

Navigation